Friday, June 5, 2009
We're Going To Be Friends
Thursday, June 4, 2009
You Know What You Can do With Quinoa?

Tuesday, June 2, 2009
Word Play
Monday, June 1, 2009
I Thought There was no Money There...
“Global Vaccine Market Forecast to 2012”, our new research report, states that vaccines, which were earlier thought as a low margin, low growth industry, have emerged as one of the most lucrative segments in the pharmaceutical industry. With a projected CAGR growth of over 16% in the next five years, the industry will emerge as the fastest growing therapy area. The US and Europe represents the two largest vaccine markets (in fact, these tow countries were the largest markets in 2007) and will continue to experience healthy growth in future.
Owing to lower margins and the mature nature of these markets, the basic and enhanced pediatric markets are expected to show stagnant growth in future. On the other hand, launch of a number of new vaccines will make the addiction, cancer and proprietary pediatrics/adolescent vaccine market highly dynamic. On a whole, the global vaccine market is expected to register revenues in excess of US$ 30 Billion by 2012.
